Integrating Medicare and Medicaid Coverage for Dual Eligibles—Recommendations for Reform
JAMA · 01.08.2023 · 330 (5) · 409
DOI: 10.1001/jama.2023.8879 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 01.08.2023. Verfasst von Eric T Roberts und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Medicaid, Medicare. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NIA NIH HHS.
Abstract (Originalsprache)
This Viewpoint highlights costly inefficiencies in delivery of care to patients who qualify to receive both Medicare and Medicaid and proposes more effective care models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
- Division of General Medical Sciences, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
- Department of Health Policy and Management, Harvard T. H. Chan School of Public Health and Brigham and Women's Hospital, Boston, Massachusetts.
Förderung
- AHRQ HHS
- NIA NIH HHS
Zitieren
APA
Roberts, E. T., Johnston, K. J., & Figueroa, J. F. (2023). Integrating Medicare and Medicaid Coverage for Dual Eligibles—Recommendations for Reform. JAMA, 330(5), 409. https://doi.org/10.1001/jama.2023.8879
Vancouver
Roberts ET, Johnston KJ, Figueroa JF. Integrating Medicare and Medicaid Coverage for Dual Eligibles—Recommendations for Reform. JAMA. 2023;330(5):409. doi:10.1001/jama.2023.8879
BibTeX
@article{Roberts2023,
author = {Roberts, Eric T and Johnston, Kenton J and Figueroa, Jose F},
title = {Integrating Medicare and Medicaid Coverage for Dual Eligibles—Recommendations for Reform},
journal = {JAMA},
year = {2023},
volume = {330},
number = {5},
pages = {409},
doi = {10.1001/jama.2023.8879}
}
EUVIMED